Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
Client: ALLIANCE FOR AGING RESEARCH · Firm: VENABLE LLP
Capping Medicare Part D Out of Pocket Costs Smoothing Medicare Part D Out of Pocket Costs Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Implementation of Inflation Reduction Act Medicare use of CED and QALY FY 2024 and FY 2025 appropriations HR 4096 Medicare coverage of treatment of Alzheimer's
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
Client: ALLIANCE FOR AGING RESEARCH · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2024 · first_quarter · 1A
FY 2024 and FY 2025 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles. HRSA / MCHB FY 2025 Appropriations coordination of pediatric to adult medical care VA Spina Bifida Agent Orange Program
Spina Bifida Awareness Month Congressional Spina Bifida Caucus Medicare coverage of Transanal Irrigation Medicare coverage of orthotic shoes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
Client: ALLIANCE FOR AGING RESEARCH · Firm: VENABLE LLP
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Menopause research, awareness, and education; The Menopause Research and Equity Act of 2023 (H.R. 6749)
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act and its implementation.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act and its implementation.
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2024 · first_quarter · Q1
Capping Medicare Part D Out of Pocket Costs Smoothing Medicare Part D Out of Pocket Costs Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Implementation of Inflation Reduction Act Medicare use of CED and QALY FY 2024 and FY 2025 appropriations HR 4096 Medicare coverage of treatment of Alzheimer's
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2024 · first_quarter · Q1
FY 2024 and FY 2025 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles. HRSA / MCHB FY 2025 Appropriations coordination of pediatric to adult medical care VA Spina Bifida Agent Orange Program
Spina Bifida Awareness Month Congressional Spina Bifida Caucus Medicare coverage of Transanal Irrigation Medicare coverage of orthotic shoes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LET'S TALK MENOPAUSE via VENABLE LLP
2023 · fourth_quarter · Q4
Menopause research, awareness, and education; The Menopause Research and Equity Act of 2023 (H.R. 6749)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2023 · fourth_quarter · Q4
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2023 · fourth_quarter · Q4
Spina Bifida Awareness Month
FY 2024 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2023 · third_quarter · Q3
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LET'S TALK MENOPAUSE via VENABLE LLP
2023 · third_quarter · Q3
Menopause research, awareness, and education
Filing targets: HOUSE OF REPRESENTATIVES
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2023 · third_quarter · Q3
FY 2024 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Spina Bifida Awareness Month
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LET'S TALK MENOPAUSE via VENABLE LLP
2023 · second_quarter · Q2
Menopause research, awareness, and education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2023 · second_quarter · Q2
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2023 · second_quarter · Q2
Spina Bifida Awareness Month
FY 2024 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LET'S TALK MENOPAUSE via VENABLE LLP
2023 · second_quarter · RR
Federal menopause research
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2023 · first_quarter · Q1
Spina Bifida Awareness Month
FY 2024 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2023 · first_quarter · Q1
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; implementation of Inflation Reduction Act; Medicare use of CED and QALY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2022 · fourth_quarter · Q4
Medicare quality measures for long-term care and skilled nursing facilities.
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act and its implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2022 · fourth_quarter · Q4
Spina Bifida Awareness Month.
FY 2022 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2022 · third_quarter · Q3
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities and Medicare quality measures; H.R. 5376 - Inflation Reduction Act.
Medicare quality measures for long-term care and skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2022 · third_quarter · Q3
Spina Bifida Awareness Month.
FY 2022 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2022 · second_quarter · Q2
FY 2022 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Spina Bifida Awareness Month.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2022 · second_quarter · Q2
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Quality measures for long-term care and skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2022 · first_quarter · Q1
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Broadening the Part D Low-Income Subsidy; Medicare Part B and Part D drug pricing; Part D appeals process and patient protections; S. 2327 - Seniors Prescription Drug Relief Act; Quality of care in skilled nursing facilities.
Quality measures for long-term care and skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2022 · first_quarter · Q1
Spina Bifida Awareness Month.
FY 2022 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC and CMS dual eligibles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via VENABLE LLP
2022 · first_quarter · RR
Appropriations for CDC and NIH; telehealth; wheelchair accessories; DME
Appropriations for CDC and NIH; telehealth; wheelchair accessories; DME
ALLIANCE FOR AGING RESEARCH via VENABLE LLP
2022 · first_quarter · RR
Medicare Part D restructuring and reducing out of pocket costs; improving care for people with dementia and neuropsychiatric symptoms in long-term care
Medicare Part D restructuring and reducing out of pocket costs; improving care for people with dementia and neuropsychiatric symptoms in long-term care
Medicare Part D restructuring and reducing out of pocket costs; improving care for people with dementia and neuropsychiatric symptoms in long-term care